TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
about
Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infectionToll Like Receptors Signaling Pathways as a Target for Therapeutic InterventionsSalmonella Typhi Porins OmpC and OmpF Are Potent Adjuvants for T-Dependent and T-Independent Antigens.Salmonella Typhi OmpS1 and OmpS2 porins are potent protective immunogens with adjuvant properties.The role of lipopeptidophosphoglycan in the immune response to Entamoeba histolytica.Evolution of Salmonella Typhi outer membrane protein-specific T and B cell responses in humans following oral Ty21a vaccination: A randomized clinical trialDifferential effect of TLR2 and TLR4 on the immune response after immunization with a vaccine against Neisseria meningitidis or Bordetella pertussis.A novel M2e based flu vaccine formulation for dogs.T helper cell- and CD40-dependent germline IgM prevents chronic virus-induced demyelinating diseaseThe Role of TLR2 in Infection and ImmunityThe FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activityInnate pathways to B-cell activation and tolerance.Toll-like receptor 2-dependent activity of native major outer membrane protein proteosomes of Chlamydia trachomatisTLR stimulation of bone marrow lymphoid precursors from childhood acute leukemia modifies their differentiation potentials.Vaccination against Salmonella Infection: the Mucosal Way.Recognition by Toll-like receptor 2 induces antigen-presenting cell activation and Th1 programming during infection by Neospora caninum.Subversion of innate and adaptive immune activation induced by structurally modified lipopolysaccharide from Salmonella typhimurium.Immunization with r-Lactococcus lactis expressing outer membrane protein A of Shigella dysenteriae type-1: evaluation of oral and intranasal route of administration.IgG Responses to Porins and Lipopolysaccharide within an Outer Membrane-Based Vaccine against Nontyphoidal Salmonella Develop at Discordant Rates.
P2860
Q21131435-2F161465-1606-4055-841B-FB860299B131Q29248835-2D995E5C-4DE0-4E02-880D-F8D246D6AFA5Q30400261-21F6D27A-6288-4A53-BAF7-1FAD2351142CQ30427484-F617C429-B425-403C-8224-E8B39D9B4011Q33633292-B723BAA0-A496-4FF2-916B-FE81653ED267Q33751908-438D30EA-9C95-48FC-AB4D-6B9CF637A91DQ33784386-FC06F5DB-25EE-4427-B4C6-36834D24E4E1Q35009732-F2A3867E-1190-4060-AA63-A4AD1EAB7226Q35708880-07C50C5B-796C-41E3-9C93-9F7ECAD636BEQ35927566-3C404FAA-2FDF-4210-BB2D-05EAF5380980Q36086244-E3C59501-288A-4E23-B971-818744088188Q36172913-CC9B8D86-E7DC-4779-B965-7C54413C42CEQ36506098-B0174DBD-0DEA-4106-8A9B-89CA963A9CA0Q37196874-DB5DCEBE-ADA0-42BE-A692-C956D426BAD6Q39373957-88225398-56DC-4CF4-B080-6581A9792782Q39881461-038C996C-7BE1-409B-BFFD-66FAA0E788C1Q50041674-321C271E-28BB-4A53-A9E3-77DB88E8E9A4Q51320080-E88B088F-5A32-4E5D-9497-8B0EADCEEC67Q52365266-B3F3F45E-284F-49B8-8B8C-A99BDB18CB8E
P2860
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@en
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@nl
type
label
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@en
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@nl
prefLabel
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@en
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens.
@nl
P2093
P2860
P50
P356
P1476
TLR2 and TLR4 signaling shapes specific antibody responses to Salmonella typhi antigens
@en
P2093
Armando Isibasi
Karl S Lang
Luisa Cervantes-Barragán
P2860
P304
P356
10.1002/EJI.200838185
P407
P50
P577
2009-01-01T00:00:00Z